Written and maintained by CASRAI Editorial Board
Published · Last updated
On this page
Short Answer
Mammalian cell culture is the laboratory propagation of cells derived from humans or animals in an artificial in vitro environment mimicking in vivo conditions. Maintained at 37°C, pH 7.2–7.4, 5% CO₂, and high humidity, cultures support drug discovery, toxicology, vaccine production, and disease modeling without live animal testing, guided by Good Cell Culture Practice (GCCP 2.0) quality standards.
Definition and Scope
Mammalian cell culture encompasses the isolation, maintenance, subculturing, and cryopreservation of eukaryotic cells derived from human or animal tissue. Unlike microbial systems that replicate in basic nutrient broths, mammalian cells require specialized formulations containing amino acids, vitamins, trace elements, and precise physicochemical buffering. Mammalian cell systems fall into two primary classifications:
- Primary Cells: Harvested directly from living donor tissue through enzymatic or mechanical dissociation. While primary cultures reflect original tissue genetics and physiology, they undergo replicative senescence after a finite number of population doublings (the Hayflick limit).
- Continuous (Immortalized) Cell Lines: Derived from primary tissue or tumors, continuous lines have acquired indefinite proliferative capacity spontaneously or through viral or oncogenic transformation (such as SV40 or hTERT expression). Standard continuous lines—including Chinese Hamster Ovary (CHO), HeLa, and Human Embryonic Kidney 293 (HEK293)—serve as scalable platforms for biomanufacturing and chemical screening.
Modern culture scope extends beyond 2D planar plastic surfaces to 3D spheroids, organoids, and microphysiological systems, which replicate organotypic architecture and cell-matrix signaling in vitro.
How It Works or How It Is Used in Practice
Mammalian cells require continuous replication of physiological homeostasis. Sourced from the ATCC Animal Cell Culture Guide and Good Cell Culture Practice 2.0 (GCCP 2.0, Pamies et al., 2022), laboratory workflows rely on four operational pillars:
1. Microenvironment and Gas Buffering
Cultures are maintained in humidified incubators set to 37.0°C ± 0.5°C and ≥ 95% relative humidity. Physiological pH (7.2 to 7.4) is regulated through equilibrium between dissolved sodium bicarbonate (1.5 to 2.2 g/L NaHCO₃) in the media and an incubator atmosphere of 5% CO₂. When handling vessels outside controlled chambers, researchers supplement media with 10 to 25 mM HEPES buffer to sustain physiological pH independently of atmospheric CO₂.
2. Culture Media and Supplements
Basal liquid media supply glucose, essential amino acids, and vitamins. Formulation selection depends on cellular lineage; standard basals include DMEM vs RPMI 1640. Media historically require supplementation with 5% to 10% fetal bovine serum (FBS) to deliver hormones, transport proteins, and adhesion factors. Biomanufacturing facilities increasingly employ chemically defined, animal-origin-free serum-free vs serum-containing cell culture media to eliminate batch variability and pathogen risks.
3. Aseptic Containment and Subculturing
Open procedures occur inside Class II biosafety cabinets using HEPA filtration. Adherent monolayers are monitored under inverted phase-contrast microscopy and subcultured upon reaching 70% to 80% confluence to prevent contact inhibition. After rinsing with divalent cation-free PBS, detachment is achieved with 0.05% to 0.25% Trypsin-EDTA, rapidly quenched with serum or trypsin inhibitors before reseeding at optimized split ratios. Per-vessel seeding densities and media volumes are listed in the cell culture reference numbers.
4. Cryopreservation and Banking Architecture
To preserve genomic stability, log-phase cells are frozen in growth media with 5% to 10% dimethyl sulfoxide (DMSO). Freezing containers cool vials at −1°C per minute before transfer to liquid nitrogen storage (≤ −130°C to −196°C). Under US FDA biologics guidance (21 CFR 610), facilities maintain a two-tiered cell bank: an authenticated Master Cell Bank (MCB) and working cell banks (WCBs), restricting cumulative population doublings.
Types or Related Concepts
The table below summarizes the four primary mammalian cell culture systems, synthesized from ATCC, GCCP 2.0, and NIH Assay Guidance Manual specifications.
| System Category | Biological Lifespan | Karyotypic Stability | Adherence Mode | Biosafety Level (BSL) | Primary Research & Industrial Uses |
|---|---|---|---|---|---|
| Primary Cells | Finite (10–50 population doublings) | Normal diploid; donor-representative | Predominantly adherent | BSL-1 or BSL-2 | Toxicology, primary pharmacology, patient disease modeling |
| Finite Cell Strains | Finite (30–60 doublings, e.g., WI-38, MRC-5) | Stable diploid; uniform senescence | Adherent monolayer | BSL-1 or BSL-2 | Viral vaccine manufacturing (rubella, rabies), cytogenetics |
| Continuous Cell Lines | Indefinite / Immortalized | Aneuploid; subject to genetic drift | Adherent or suspension (CHO, HEK293) | BSL-1 or BSL-2 | Therapeutic protein biomanufacturing, high-throughput screening |
| 3D Organoids | Variable (stem-cell derived) | Reflects source tissue phenotype | Suspension or hydrogel embedded | BSL-1 or BSL-2 | Organ-level physiological screening, disease modeling |
Where It Matters for Labs, Clinics or Supply Decisions
Mammalian cell culture workflows dictate critical facility operations, consumable procurement, and regulatory quality controls:
- Vessel Surface Chemistry: Anchorage-dependent cells cannot attach to untreated polystyrene. Facilities must procure tissue-culture-treated plasticware modified via gas-plasma discharge, which creates negatively charged hydrophilic surfaces. Delicate primary lines require coating with collagen, fibronectin, or poly-D-lysine.
- Cell Authentication: Sourced from the NIH Assay Guidance Manual and ANSI/ATCC ASN-0002 standard, human cell lines require Short Tandem Repeat (STR) profiling across at least 8 core microsatellite loci (plus amelogenin). Routine STR authentication prevents cross-contamination, which historically affected 15% to 30% of cell lines through unnoticed HeLa overgrowth.
- Passage Limit Governance: GCCP 2.0 mandates working within a defined passage window (< 15 to 20 passages from an authenticated working bank). Serial over-passaging promotes aneuploidy, altered growth kinetics, and loss of specialized protein expression.
- Mycoplasma Surveillance: Lacking a cell wall, mycoplasma species (e.g., M. hyorhinis) pass through 0.22 μm filters without causing turbidity or pH shifts. Labs must conduct regular surveillance using PCR, fluorochrome DNA staining, or microbiological agar culture.
- Serum Batch Qualification: Natural FBS lots vary in growth factors and endotoxin content. Facilities must perform lot-reservation testing on target cell lines before committing to bulk purchases.
Common Misunderstandings
- Misunderstanding 1: Antibiotics replace aseptic technique. Routine use of penicillin-streptomycin does not compensate for poor biosafety cabinet discipline. Prophylactic antibiotics mask low-grade contamination, foster resistant strains, and alter gene expression. GCCP 2.0 advises against continuous antibiotic supplementation in master stocks.
- Misunderstanding 2: Immortalized cell lines remain genetically constant. While continuous lines divide indefinitely, they remain under ongoing selective pressure. Passaging causes chromosomal rearrangements and variable drug sensitivity. Returning to authenticated cryopreserved seed stocks ensures reproducibility.
- Misunderstanding 3: Clear media confirms the absence of contamination. Although bacterial and fungal infections cloud media rapidly, mycoplasma and viral contaminants leave media completely clear while altering cellular metabolism and experimental outcomes.
- Misunderstanding 4: Primary cells can be propagated identically to cell lines. Primary cultures cannot tolerate the rapid subculturing or harsh enzymatic digestion tolerated by continuous lines. They require gentle dissociation, lower seeding densities, and specialized growth factor supplements.
Frequently Asked Questions
What are cell culture?
Cell culture is the biological technique of removing cells from an animal, plant, or microbe and cultivating them in an artificial in vitro environment. In mammalian biology, the process requires liquid media supplying amino acids and vitamins, precise temperature (37°C) and gas buffering (5% CO₂), and sterile handling to sustain cellular growth, metabolism, and division outside living organisms.
What is the difference between adherent and suspension cell cultures?
Adherent cultures require anchorage to a solid, treated substrate (such as plasma-treated plastic) to spread and divide, requiring enzymatic detachment during passaging. Suspension cultures grow freely floating in liquid media without attachment, enabling volumetric scale-up in stirred bioreactors for therapeutic protein production.
Why is a 5% CO2 atmosphere necessary for mammalian cell culture?
Mammalian media employ a dissolved sodium bicarbonate buffer system to mimic natural blood buffering. An incubator atmosphere of 5% gaseous CO₂ maintains dissolved carbon dioxide in chemical equilibrium, preventing outgassing that would otherwise cause media pH to become dangerously alkaline.
How often should cell lines be authenticated with STR profiling?
Per ATCC repository guidelines and the NIH Assay Guidance Manual, human cell lines should undergo STR profiling upon acquisition, before creating Master Cell Banks, at the end of key experimental projects, and whenever abnormal cell morphology or growth rates occur.
Sources
- ATCC. Animal Cell Culture Guide: Tips and Techniques for Continuous Culture. American Type Culture Collection. https://www.atcc.org/resources/culture-guides/animal-cell-culture-guide (accessed 2026-11-09).
- Pamies D, Leist M, Coecke S, et al. Guidance document on Good Cell and Tissue Culture Practice 2.0 (GCCP 2.0). ALTEX – Alternatives to Animal Experimentation, 2022; 39(1):30–70. DOI: 10.14573/altex.2111011 (accessed 2026-11-09).
- Reid Y, Storts D, Riss T, Minor L. Authentication of Human Cell Lines by STR DNA Profiling. In: Markossian S, Grossman A, Brimacombe K, et al., editors. Assay Guidance Manual. Bethesda (MD): Eli Lilly & Company and NCATS; 2013–. https://www.ncbi.nlm.nih.gov/books/NBK53196/ (accessed 2026-11-09).
- US Food and Drug Administration (FDA) / Center for Biologics Evaluation and Research (CBER). Characterization and Qualification of Cell Substrates and Other Biological Materials Used in the Production of Viral Vaccines for Infectious Disease Indications. 21 CFR 610. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/characterization-and-qualification-cell-substrates-and-other-biological-materials-used-production (accessed 2026-11-09).







